[Modification of personality changes in epileptics using dipropylacetate (Convulex). Preliminary communication].
D000293:Adolescent; D000927:Anticonvulsants / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004827:Epilepsy / Q000150:complications* / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D010554:Personality Disorders / Q000188:drug therapy* / Q000209:etiology; D014631:Valerates / Q000627:therapeutic use*; D014635:Valproic Acid / Q000627:therapeutic use*
D000927:Anticonvulsants; D014631:Valerates; D014635:Valproic Acid
Beeinflussung der Wesensveränderung Anfallskranker durch Dipropylazetat (Convulex). Vorläufige Mitteilung.